-
Aug. 5, 2025
IR
Announcement of a Subsidiary's Submission of the Application of Manufacturing and Marketing Authorization for an iPS Cell-Derived Product for Parkinson's Disease in Japan
-
Aug. 1, 2025
IR
Sumitomo Chemical Reports Unrealized Losses on Securities as of June 30, 2025
-
Aug. 1, 2025
IR
Notice Concerning Finance Expenses (Foreign Exchange Loss)
-
Aug. 1, 2025
IR
Summary of Consolidated Financial Results for First Quarter Fiscal Year 2025
-
Jul. 31, 2025
IR
(Progress of Disclosure Matters) Notice Regarding Completion of Procedures for a Company Split (Simplified Absorption-Type Company Split) by a Subsidiary
-
Jul. 18, 2025
IR
Notice Regarding Payment Completed of New Shares as Restricted Stock Compensation
-
Jun. 20, 2025
IR
Notice Regarding Issuance of New Shares as Restricted Stock Compensation
-
May. 22, 2025
Announcements
Notice of the 144th Ordinary General Meeting of Shareholders has been published.
-
May. 14, 2025
IR
Summary of Consolidated Financial Results for Fiscal Year 2024
-
May. 14, 2025
IR
Notice Concerning Impairment Loss and Finance Expenses (Foreign Exchange Loss)
-
May. 14, 2025
Organization
Notice Regarding Changes in Representative Director
-
May. 14, 2025
IR
Notice Regarding Partial Amendments to the Articles of Incorporation
-
May. 13, 2025
IR
Notice Concerning Variances between Non-Consolidate Financial Results in Consolidated Subsidiaries for Fiscal Year 2024 and Fiscal Year 2023
-
Apr. 30, 2025
IR
Sumitomo Chemical Announces Revisions to Its Financial Forecast for the Full Year Ending March 31, 2025
-
Apr. 1, 2025
IR
Notice Regarding Company Split (Simplified Absorption-Type Company Split) Etc. by the Company's Subsidiary
-
Mar. 5, 2025
IR
"FY2025-FY2027 Corporate Business Plan" has been released.
-
Mar. 4, 2025
Business & Products
Sumitomo Chemical Launches Three-Year Corporate Business Plan for Fiscal
2025 to 2027 with the Slogan Leap Beyond: Returning to a Growth Trajectory -
Mar. 3, 2025
IR
Notice Regarding Sumitomo Chemical's Transition to a Company with an Audit and Supervisory Committee
-
Feb. 6, 2025
IR
Sumitomo Chemical Agrees to Accept a Tender Offer by Dai Nippon Toryo for Shares of an Associate Accounted for Using the Equity Method
-
Feb. 4, 2025
IR
Notice Regarding the Recording of Extraordinary Income in Non-Consolidated Financial Statements Due to the Transfer of a Portion of Shares Held by Sumitomo Chemical in Sumitomo Bakelite